Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
This explainer defines global market indices, explains their purpose, and outlines how they aggregate data from multiple markets.
27,297 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
In a landscape defined by budget cycles and rapid tech shifts, L3Harris Technologies stands out with a 7.1 rating in ...
As major retailers push Beyond Meat into the frozen aisle, investors debate the stock's trajectory. This guide breaks...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
SSR Mining's move to sell a large stake in a key asset sent its stock higher in a single session. This article breaks...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
Could Ethereum steal the spotlight from Bitcoin in the next three years? This guide lays out the case, the risks, and...
PayPal reports a solid quarter but the stock falls as the company commits to an AI-driven reorganization. The legacy ...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
As Absci releases its 2026 earnings outlook, investors gain a clearer view of runway, milestones, and collaboration p...
April brought a notable rebound for UnitedHealth Group Stock. This article breaks down the earnings, margin improveme...
Apple signals a strategic pivot, moving its flagship away from the iPhone toward ambient computing with Vision Pro an...